Skip to content

Management of Tamaka Swasa with special reference to Bronchial Asthma with Kulattha Guda

A clinical study on Tamaka Swasa w.s.r to Bronchial Asthma and its management with Kulattha Guda - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/069912
Enrollment
60
Registered
2024-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Sponsors

Dr Lopamudra Bag
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical symptoms of Tamaka swasa Viz. Swasakruchhata (Dyspnoea), Rudhha Ghurghurakam(Wheezing),Urahpida(Chest tightness), Peenasa(Rhinitis) etc.

Exclusion criteria

Exclusion criteria: Other diseases like Left ventricular failure, COPD, Upper respiratory tract obstruction, Bronchiectasis, Cases of Tuberculosis, occupational lungs disease, Tropical pulmonary eosinophilia, etc Patient who need salbutamol inhaler daily Diabetes mellitus and hypertension Pregnant or lactating mother

Design outcomes

Primary

MeasureTime frame
To reduce the classical symptoms of Tamaka Swasa like dyspnoea, wheezing, chest tightness, rhinitis etc.Timepoint: 30days

Secondary

MeasureTime frame
To reduce chest tightness & running noseTimepoint: 30days

Countries

India

Contacts

Public ContactDr Sonalika Jena

Gopabandhu Ayurveda Mahavidyalaya Puri, Odisha

drsonalikajena@gmail.com9437281398

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026